WarfarinAnticoagulantsInternational Normalized RatioThromboembolismHemorrhageProthrombin TimeVitamin K Epoxide ReductasesBlood CoagulationAtrial FibrillationHeparinbeta-AlanineAcenocoumarolVitamin KPartial Thromboplastin TimeVenous ThrombosisThrombosisLupus Coagulation InhibitorHeparin, Low-Molecular-WeightPhenprocoumonRodenticidesAntithrombins4-HydroxycoumarinsPulmonary EmbolismVenous ThromboembolismProtein CWhole Blood Coagulation TimeBlood Coagulation TestsAdministration, OralDrug MonitoringPhenindioneFactor XaThrombophlebitisHeparin AntagonistsStrokeAspirinBlood Coagulation FactorsProthrombinPlatelet Aggregation InhibitorsFibrinolytic AgentsThrombin TimeTreatment OutcomeAntiphospholipid SyndromeBlood Coagulation DisordersThrombophiliaMixed Function OxygenasesEmbolismProtein SEnoxaparinBenzimidazolesHeart Valve ProsthesisAryl Hydrocarbon HydroxylasesPharmacogeneticsIntracranial HemorrhagesHirudinsThrombinThrombomodulinHematomaThiophenesRisk FactorsPipecolic AcidsFibrin Fibrinogen Degradation Products